Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment.
"Gingival enlargement" is the term now used to describe medication-related gingival overgrowth or gingival hyperplasia (AAP, 2004), a condition commonly induced by three main classes of drugs: anticonvulsants, antihypertensive calcium antagonists and the immunosuppressant cyclosporin. It is important that the health practitioner is aware of the potential aetiologic agents and characteristic features in order to be able to accurately diagnose and successfully manage patients who present with a condition such as outlined in the following case presentation.
Eggerath
Jobst
J
Department of Oral Rehabilitation, School of Dentistry, University of Otago, Dunedin.
English
Helen
H
Leichter
Jonathan W
JW
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects; D003663:Decision Trees; D003773:Dental Plaque / Q000517:prevention & control; D015736:Felodipine / Q000009:adverse effects*; D005885:Gingival Hyperplasia / Q000139:chemically induced* / Q000188:drug therapy / Q000601:surgery; D005890:Gingivectomy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use
D000890:Anti-Infective Agents; D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D008795:Metronidazole; D016572:Cyclosporine; D015736:Felodipine